首页> 外文期刊>BMC Psychiatry >Mindfulness-based crisis interventions (MBCI) for psychosis within acute inpatient psychiatric settings; a feasibility randomised controlled trial
【24h】

Mindfulness-based crisis interventions (MBCI) for psychosis within acute inpatient psychiatric settings; a feasibility randomised controlled trial

机译:急性入住性精神病环境中的心理效应(MBCI)基于忠诚的危机干预;可行性随机对照试验

获取原文
           

摘要

BACKGROUND:Inpatient psychiatric care is a scarce and expensive resource in the National Health Service (NHS), with chronic bed shortages being partly driven by high re-admission rates. Brief inpatient talking therapies for psychosis could help reduce re-admission rates. The primary aim was to assess feasibility and acceptability of a novel, brief, mindfulness-based intervention for inpatients with psychosis. The secondary aim was to collect pilot outcome data on readmission rate, at 6 and 12?months (m) post discharge, and self-report symptom measures at 6?m.METHODS:The amBITION study (BrIef Talking therapIes ON wards) was a parallel group, feasibility randomised controlled trial (RCT). In addition to treatment as usual (TAU), eligible inpatients with psychotic symptoms were randomly allocated to receive either (Mindfulness-Based Crisis Intervention; MBCI) or a control intervention (Social Activity Therapy; SAT), for 1-5 sessions.RESULTS:Fifty participants were recruited (26 MBCI; 24 SAT); all received at least 1 therapy session (mean?=?3). Follow-up rates were 98% at 6?m and 96% at 12?m for service use data extracted from clinical notes, and 86% for self-report measures. At 6?m follow-up, re-admission rates were similar across groups (MBCI?=?6, SAT?=?5; odds ratio?=?1.20, 95% CI: 0.312-4.61). At 12?m follow-up, re-admissions were lower in the MBCI group (MBCI?=?7, SAT?=?11; odds ratio?=?0.46, 95% CI: 0.14-1.51). Three participants experienced adverse events; none was related to trial participation.CONCLUSIONS:Delivering a brief mindfulness-based inpatient intervention for psychosis is feasible and acceptable, and may reduce risk of short-term readmission. These promising findings warrant progression to a larger clinical effectiveness trial.TRIAL REGISTRATION:ISRCTN37625384.
机译:背景:住院精神疗养是国家卫生服务(NHS)的稀缺和昂贵的资源,慢性臭氧短缺部分由高再次入学率部分驱动。简短的住院人员对精神病疗法有助于减少重新入场费。主要目的是评估新颖,简介的基于内心的干预性的可行性和可接受性,用于有精神病的住院患者。二次目的是收集关于再入院率的试点结果数据,在6和12月(m)后出院,以及6?M.Methods的自我报告症状措施:野心研究(在病房上短暂说话疗法)是一个并行组,可行性随机对照试验(RCT)。除了常规(TAU)的治疗外,随机分配有精神病症状的合格住院患者,以获得(谨慎为基础的危机干预; MBCI)或控制干预(社会活动治疗; SAT),用于1-5个会议。结果:招募了五十名参与者(26 MBCI; 24星期六);所有人都收到至少1个治疗会议(平均值?=?3)。随访率为6?M的68%,9.米为12?M,用于从临床票据提取的数据,86%的自我报告措施为9.米。在6?M后续后,重新入学率在跨组相似(MBCI?=?6,SAT?=?5; odds比率?=?1.20,95%CI:0.312-4.61)。在12?M后续后,在MBCI组中重新入院(MBCI?=?7,坐坐?=?11; odds比率?= 0.46,95%CI:0.14-1.51)。三位参与者经历过不良事件;没有与试验参与有关。结论:提供简短的谨慎的住院性干预性能是可行和可接受的,并且可能降低短期入院风险。这些有希望的调查结果需要提高临床有效性试验的进展。注册:ISRCTN37625384。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号